- 腎內(nèi)科學(xué)(第2版)
- 諶貽璞主編
- 1237字
- 2021-04-16 12:54:48
參考文獻(xiàn)
1.黃頌敏.糖尿病腎病//諶貽璞.腎內(nèi)科學(xué).北京:人民衛(wèi)生出版社,2008,70-86.
2. Shan G,Yang W,Xiao J,et al. Prevalence of diabetes among men and women in China.N Engl J Med,2010,362 (12):1090-1101.
3. Xu Y,Wang L,He J,et al.Prevalence and control of diabetes in Chinese adults.JAMA,2013,310(9):948-959.
4. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease.Am J Kidney Dis,2007,49:S1-S180.
5. National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes and CKD:2012 update.Am J Kidney Dis,2012,60(5):850-886.
6. American Diabetes Association.Standards of medical care in diabetes-2013.Diabetes Care,2013,36(1):S11-S66.
7. Tervaert TW,Mooyaart AL,Amann K,et al. Pathologic classification of diabetic nephropathy.J Am Soc Nephrol,2010,21(4):556-563.
8. Kanwar YS,Sun L,Xie P,et al.A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol,2011,6(1):395-423.
9. Stitt-Cavanagh E,MacLeod L,Kennedy C.The podocyte in diabetic kidney disease.Scientific World Journal,2009,9:1127-1139.
10. Weil EJ,Lemley KV,Mason CC,et al.Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.Kidney Int,2012,82(9):1010-1017.
11. Gilbert RE.The endothelium in diabetic nephropathy.Curr Atheroscler Rep,2014,16(5):410.
12. Habib SL.Diabetes and renal tubular cell apoptosis.World J Diabetes,2013,4(2):27-30.
13. Lim AK,Tesch GH.Inflammation in diabetic nephropathy.Mediators Inflamm,2012,2012:146-154.
14. Wada J,Makino H.Inflammation and the pathogenesis of diabetic nephropathy.Clin Sci,2013,124(3):139-152.
15.楊玉璽,黃頌敏,顏驍勇,等.糖尿病腎病模型中NF-κB與甘露聚糖結(jié)合凝集素途徑補(bǔ)體激活的關(guān)系.四川大學(xué)學(xué)報(醫(yī)學(xué)版),2011,42(4):490-493.
16.邱紅渝,樊文星,黃頌敏,等.高糖對人腎小球內(nèi)皮細(xì)胞膜表面多糖-蛋白復(fù)合物厚度及核心蛋白Syndecan-1和Glypican-1表達(dá)的影響.四川大學(xué)學(xué)報(醫(yī)學(xué)版),2010,41(6):980-985.
17. Mooyaart AL,Valk EJ,van Es LA,et al.Genetic associations in diabetic nephropathy:a meta-analysis.Diabetologia,2011,54(3):544-553.
18. Kato M,Natarajan R.microRNA cascade in diabetic kidney disease:Big impact initiated by a small RNA.Cell Cycle,2009,8(22):3613-3614.
19. Khella HW,Bakhet M,Lichner Z,et al.MicroRNAs in kidney disease:an emerging understanding.Am J Kidney Dis,2013,61(5):798-808.
20. Smith AC,Burton JO.Exercise in kidney disease and diabetes:time for action.J Ren Care.2012,38 Suppl 1:52-58.
21.α酮酸制劑在腎內(nèi)科應(yīng)用專家協(xié)作組.慢性腎臟病蛋白營養(yǎng)治療共識.中華腎臟病雜志,2005,21(7):421-424.
22. Haimoto H,Sasakabe T,Umegaki H,et al.Reduction in urinary albumin excretion with a moderate low-carbohydrate diet in patients with type 2 diabetes:a 12-month intervention.Diabetes Metab Syndr Obes,2012,5:283-291.
23.中華醫(yī)學(xué)會內(nèi)分泌學(xué)分會.中國成人2型糖尿病HbA1c控制目標(biāo)的專家共識.中國醫(yī)學(xué)前沿雜志(電子版),2011,3(4):73-77.
24.中國醫(yī)師協(xié)會內(nèi)分泌代謝科醫(yī)師分會.2型糖尿病合并慢性腎臟病患者口服降糖藥應(yīng)用原則的中國專家共識.中國糖尿病雜志,2013,21(10):865-870.
25. Mancia G,F(xiàn)agard R,Narkiewicz K,et al.2013 ESH/ESC Guidelines for the management of arterial hypertension:The Task Force for the management of arterial hypertension of the European Society of Hypertension(ESH)and of the European Society of Cardiology(ESC).J Hypertens,2013,31(7):1281-1357.
26. James PA,Oparil S,Carter BL,et al.2014 evidence-based guideline for the management of high blood pressure in adults:report from the panel members appointed to the Eighth Joint National Committee(JNC 8).JAMA,2014,311(5):507-520.
27. Kidney Disease:Improving Global Outcomes(KDIGO)Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease.Kidney Int Suppl,2012,2:337-414.
28. Mancia G,Laurent S,Agabiti-Rosei E,et al.Reappraisal of European guidelines on hypertension management:a European Society of Hypertension Task Force document.J Hypertens.2009,27(11):2121-2158.
29. Fernandez Juarez G,Lu?o J,Barrio V,et al;PRONEDI study group.Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy:a randomized trial.Am J Kidney Dis,2013,61(2):211-218.
30. Fried LF,Emanuele N,Zhang JH,et al;VA NEPHROND investigators. Combined angiotensin inhibition for the treatment of diabetic nephropathy.N Engl J Med,2013,369(20):1892-1903.
31. Morello CM.Pharmacokinetics and pharmacodynamics of insulin analogs in special populations with type 2 diabetes mellitus.Int J Gen Med,2011,4:827-835.
32. Weinhandl ED,F(xiàn)oley RN,Gilbertson DT,et al.Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients.J Am Soc Nephrol,2010,21(3):499-506.
33. Chang JH,Sung JY,Ahn SY,et al.Hemodialysis leads to better survival in patients with diabetes or high comorbidity,compared to peritoneal dialysis.Tohoku J Exp Med,2013,229(4):271-277.
34. Slinin Y,Ishani A,Rector T,et al.Management of hyperglycemia,dyslipidemia,and albuminuria in patients with diabetes and CKD:a systematic review for a KDOQI clinical practice guideline.Am J Kidney Dis,2012,60(5):747-769.
推薦閱讀
- 實(shí)用醫(yī)療輻射防護(hù)
- 埋線美容外科學(xué)
- 中醫(yī)藥創(chuàng)新創(chuàng)業(yè)指導(dǎo)教程(全國中醫(yī)藥行業(yè)職業(yè)教育“十四五”創(chuàng)新教材)
- 臨證實(shí)用學(xué)苑藥性賦
- 臨床護(hù)理技能實(shí)訓(xùn)(全國高等學(xué)歷繼續(xù)教育“十三五”(護(hù)理專本共用)規(guī)劃教材)
- 婦產(chǎn)科學(xué)(第2版)
- 超聲醫(yī)學(xué)
- 生理學(xué)(全國中醫(yī)藥行業(yè)高等教育“十四五”規(guī)劃教材)
- 物理化學(xué)實(shí)驗(yàn)(全國中醫(yī)藥行業(yè)高等教育“十四五”規(guī)劃教材配套用書)
- 五官科護(hù)理學(xué)(全國中醫(yī)藥行業(yè)高等教育“十四五”規(guī)劃教材)
- 人體解剖學(xué)(第4版)(全國高等學(xué)歷繼續(xù)教育“十三五”(臨床專科)規(guī)劃教材)
- 醫(yī)患溝通技能(全國中醫(yī)藥行業(yè)高等教育“十四五”規(guī)劃教材)
- 敘事醫(yī)學(xué)
- 大學(xué)生心理健康教育(全國中醫(yī)藥高等院校規(guī)劃教材)
- 社區(qū)常見疼痛疾病分級診療手冊